Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

Introduction - Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier studies did not require biomarker evidence of amyloid β (Aβ) pathology. - Methods - We included 3451 Aβ+ subjects (853 AD-type dementia, 1810 mi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mattsson, Niklas (Author) , Schröder, Johannes (Author)
Format: Article (Journal)
Language:English
Published: [July 2018]
In: Alzheimer's and dementia
Year: 2018, Volume: 14, Issue: 7, Pages: 913-924
ISSN:1552-5279
DOI:10.1016/j.jalz.2018.02.009
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.jalz.2018.02.009
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1552526018300633
Get full text
Author Notes:Niklas Mattsson, Colin Groot, Willemijn J. Jansen, Susan M. Landau, Victor L. Villemagne, Sebastiaan Engelborghs, Mark M. Mintun, Alberto Lleo, José Luis Molinuevo, William J. Jagust, Giovanni B. Frisoni, Adrian Ivanoiu, Gaël Chételat, Catarina Resende de Oliveira, Karen M. Rodrigue, Johannes Kornhuber, Anders Wallin, Aleksandra Klimkowicz-Mrowiec, Ramesh Kandimalla, Julius Popp, Pauline P. Aalten, Dag Aarsland, Daniel Alcolea, Ina S. Almdahl, Inês Baldeiras, Mark A. van Buchem, Enrica Cavedo, Kewei Chen, Ann D. Cohen, Stefan Förster, Juan Fortea, Kristian S. Frederiksen, Yvonne Freund-Levi, Kiran Dip Gill, Olymbia Gkatzima, Timo Grimmer, Harald Hampel, Sanna-Kaisa Herukka, Peter Johannsen, Koen van Laere, Mony J. de Leon, Wolfgang Maier, Jan Marcusson, Olga Meulenbroek, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Arto Nordlund, Sudesh Prabhakar, Oliver Peters, Lorena Rami, Eloy Rodríguez-Rodríguez, Catherine M. Roe, Eckart Rüther, Isabel Santana, Johannes Schröder, Sang W. Seo, Hilkka Soininen, Luiza Spiru, Erik Stomrud, Hanne Struyfs, Charlotte E. Teunissen, Frans R. J. Verhey, Stephanie J. B. Vos, Linda J. C. van Waalwijk van Doorn, Gunhild Waldemar, Åsa K. Wallin, Jens Wiltfang, Rik Vandenberghe, David J. Brooks, Tormod Fladby, Christopher C. Rowe, Alexander Drzezga, Marcel M. Verbeek, Marie Sarazin, David A. Wolk, Adam S. Fleisher, William E. Klunk, Duk L. Na, Pascual Sánchez-Juan, Dong Young Lee, Agneta Nordberg, Magda Tsolaki, Vincent Camus, Juha O. Rinne, Anne M. Fagan, Henrik Zetterberg, Kaj Blennow, Gil D. Rabinovici, Oskar Hansson, Bart N. M. van Berckel, Wiesje M. van der Flier, Philip Scheltens, Pieter Jelle Visser, Rik Ossenkoppele

MARC

LEADER 00000caa a2200000 c 4500
001 1679034855
003 DE-627
005 20240323101344.0
007 cr uuu---uuuuu
008 191017s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jalz.2018.02.009  |2 doi 
035 |a (DE-627)1679034855 
035 |a (DE-599)KXP1679034855 
035 |a (OCoLC)1341246669 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mattsson, Niklas  |e VerfasserIn  |0 (DE-588)119725837X  |0 (DE-627)1679045563  |4 aut 
245 1 0 |a Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease  |c Niklas Mattsson, Colin Groot, Willemijn J. Jansen, Susan M. Landau, Victor L. Villemagne, Sebastiaan Engelborghs, Mark M. Mintun, Alberto Lleo, José Luis Molinuevo, William J. Jagust, Giovanni B. Frisoni, Adrian Ivanoiu, Gaël Chételat, Catarina Resende de Oliveira, Karen M. Rodrigue, Johannes Kornhuber, Anders Wallin, Aleksandra Klimkowicz-Mrowiec, Ramesh Kandimalla, Julius Popp, Pauline P. Aalten, Dag Aarsland, Daniel Alcolea, Ina S. Almdahl, Inês Baldeiras, Mark A. van Buchem, Enrica Cavedo, Kewei Chen, Ann D. Cohen, Stefan Förster, Juan Fortea, Kristian S. Frederiksen, Yvonne Freund-Levi, Kiran Dip Gill, Olymbia Gkatzima, Timo Grimmer, Harald Hampel, Sanna-Kaisa Herukka, Peter Johannsen, Koen van Laere, Mony J. de Leon, Wolfgang Maier, Jan Marcusson, Olga Meulenbroek, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Arto Nordlund, Sudesh Prabhakar, Oliver Peters, Lorena Rami, Eloy Rodríguez-Rodríguez, Catherine M. Roe, Eckart Rüther, Isabel Santana, Johannes Schröder, Sang W. Seo, Hilkka Soininen, Luiza Spiru, Erik Stomrud, Hanne Struyfs, Charlotte E. Teunissen, Frans R. J. Verhey, Stephanie J. B. Vos, Linda J. C. van Waalwijk van Doorn, Gunhild Waldemar, Åsa K. Wallin, Jens Wiltfang, Rik Vandenberghe, David J. Brooks, Tormod Fladby, Christopher C. Rowe, Alexander Drzezga, Marcel M. Verbeek, Marie Sarazin, David A. Wolk, Adam S. Fleisher, William E. Klunk, Duk L. Na, Pascual Sánchez-Juan, Dong Young Lee, Agneta Nordberg, Magda Tsolaki, Vincent Camus, Juha O. Rinne, Anne M. Fagan, Henrik Zetterberg, Kaj Blennow, Gil D. Rabinovici, Oskar Hansson, Bart N. M. van Berckel, Wiesje M. van der Flier, Philip Scheltens, Pieter Jelle Visser, Rik Ossenkoppele 
246 3 3 |a Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease 
246 3 3 |a Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease 
264 1 |c [July 2018] 
300 |b Diagramme 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.10.2019 
520 |a Introduction - Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier studies did not require biomarker evidence of amyloid β (Aβ) pathology. - Methods - We included 3451 Aβ+ subjects (853 AD-type dementia, 1810 mild cognitive impairment, and 788 cognitively normal). Generalized estimating equation models were used to assess APOE ε4 prevalence in relation to age, sex, education, and geographical location. - Results - The APOE ε4 prevalence was 66% in AD-type dementia, 64% in mild cognitive impairment, and 51% in cognitively normal, and it decreased with advancing age in Aβ+ cognitively normal and Aβ+ mild cognitive impairment (P < .05) but not in Aβ+ AD dementia (P = .66). The prevalence was highest in Northern Europe but did not vary by sex or education. - Discussion - The APOE ε4 prevalence in AD was higher than that in previous studies, which did not require presence of Aβ pathology. Furthermore, our results highlight disease heterogeneity related to age and geographical location. 
650 4 |a Age 
650 4 |a Alzheimer's disease 
650 4 |a Amyloid 
650 4 |a APOE 
650 4 |a CSF 
650 4 |a Education 
650 4 |a Geographical location 
650 4 |a Mild cognitive impairment 
650 4 |a PET 
650 4 |a Prevalence 
650 4 |a Sex 
650 4 |a Subjective cognitive decline 
700 1 |a Schröder, Johannes  |d 1957-  |e VerfasserIn  |0 (DE-588)138708517  |0 (DE-627)605263469  |0 (DE-576)308769848  |4 aut 
773 0 8 |i Enthalten in  |t Alzheimer's and dementia  |d Hoboken, NJ : Wiley, 2005  |g 14(2018), 7, Seite 913-924  |h Online-Ressource  |w (DE-627)499546059  |w (DE-600)2201940-6  |w (DE-576)255666330  |x 1552-5279  |7 nnas  |a Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease 
773 1 8 |g volume:14  |g year:2018  |g number:7  |g pages:913-924  |g extent:12  |a Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease 
856 4 0 |u https://doi.org/10.1016/j.jalz.2018.02.009  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1552526018300633  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20191017 
993 |a Article 
994 |a 2018 
998 |g 138708517  |a Schröder, Johannes  |m 138708517:Schröder, Johannes  |d 910000  |d 910600  |e 910000PS138708517  |e 910600PS138708517  |k 0/910000/  |k 1/910000/910600/  |p 56 
999 |a KXP-PPN1679034855  |e 3523405599 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease","title_sort":"Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease"}],"language":["eng"],"person":[{"role":"aut","given":"Niklas","display":"Mattsson, Niklas","family":"Mattsson"},{"role":"aut","given":"Johannes","display":"Schröder, Johannes","family":"Schröder"}],"name":{"displayForm":["Niklas Mattsson, Colin Groot, Willemijn J. Jansen, Susan M. Landau, Victor L. Villemagne, Sebastiaan Engelborghs, Mark M. Mintun, Alberto Lleo, José Luis Molinuevo, William J. Jagust, Giovanni B. Frisoni, Adrian Ivanoiu, Gaël Chételat, Catarina Resende de Oliveira, Karen M. Rodrigue, Johannes Kornhuber, Anders Wallin, Aleksandra Klimkowicz-Mrowiec, Ramesh Kandimalla, Julius Popp, Pauline P. Aalten, Dag Aarsland, Daniel Alcolea, Ina S. Almdahl, Inês Baldeiras, Mark A. van Buchem, Enrica Cavedo, Kewei Chen, Ann D. Cohen, Stefan Förster, Juan Fortea, Kristian S. Frederiksen, Yvonne Freund-Levi, Kiran Dip Gill, Olymbia Gkatzima, Timo Grimmer, Harald Hampel, Sanna-Kaisa Herukka, Peter Johannsen, Koen van Laere, Mony J. de Leon, Wolfgang Maier, Jan Marcusson, Olga Meulenbroek, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Arto Nordlund, Sudesh Prabhakar, Oliver Peters, Lorena Rami, Eloy Rodríguez-Rodríguez, Catherine M. Roe, Eckart Rüther, Isabel Santana, Johannes Schröder, Sang W. Seo, Hilkka Soininen, Luiza Spiru, Erik Stomrud, Hanne Struyfs, Charlotte E. Teunissen, Frans R. J. Verhey, Stephanie J. B. Vos, Linda J. C. van Waalwijk van Doorn, Gunhild Waldemar, Åsa K. Wallin, Jens Wiltfang, Rik Vandenberghe, David J. Brooks, Tormod Fladby, Christopher C. Rowe, Alexander Drzezga, Marcel M. Verbeek, Marie Sarazin, David A. Wolk, Adam S. Fleisher, William E. Klunk, Duk L. Na, Pascual Sánchez-Juan, Dong Young Lee, Agneta Nordberg, Magda Tsolaki, Vincent Camus, Juha O. Rinne, Anne M. Fagan, Henrik Zetterberg, Kaj Blennow, Gil D. Rabinovici, Oskar Hansson, Bart N. M. van Berckel, Wiesje M. van der Flier, Philip Scheltens, Pieter Jelle Visser, Rik Ossenkoppele"]},"id":{"eki":["1679034855"],"doi":["10.1016/j.jalz.2018.02.009"]},"physDesc":[{"noteIll":"Diagramme","extent":"12 S."}],"note":["Gesehen am 17.10.2019"],"relHost":[{"pubHistory":["1.2005 -"],"title":[{"title":"Alzheimer's and dementia","subtitle":"the journal of the Alzheimer's Association","title_sort":"Alzheimer's and dementia"}],"part":{"issue":"7","extent":"12","pages":"913-924","volume":"14","year":"2018","text":"14(2018), 7, Seite 913-924"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Wiley ; Elsevier","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisherPlace":"Hoboken, NJ ; Amsterdam"}],"recId":"499546059","id":{"eki":["499546059"],"zdb":["2201940-6"],"issn":["1552-5279"],"doi":["10.1002/(ISSN)1552-5279"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseAlzheimer's and dementia","note":["Gesehen am 19.03.2024"]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"titleAlt":[{"title":"Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease"},{"title":"Prevalence of the apolipoprotein E [epsilon]4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease"}],"origin":[{"dateIssuedDisp":"[July 2018]","dateIssuedKey":"2018"}],"recId":"1679034855"} 
SRT |a MATTSSONNIPREVALENCE2018